Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
I've yet to determine what I'm good at when it comes to investing... But I do know enough to ask for advice on this forum, advice from people who have been investing much longer than I have.
Granny flat? I had to look that one up! My neighborhoo…
Thanks junkster for posting your experience. I'm probably the youngest poster on this board, so I very much value everyone's opinion/experience.
I'll watch gld & gdx for a few days. I kinda doubt that I'll put money into either of these etf…
Thanks Rono, I was wondering if you'd chime in or not!
Ramble away, I'm soaking it all in. I remember your pounding the table for pm's 5 or 6 years ago, which led to my buying GLD, CEF and GDX back then. I owe you a beer or 4, thanks!
Momentum…
Thanks Joe. I held GLD, CEF and GDX when the fed started its QE program and sold in 2011. They all did well during that time period.
My thought is exactly the scenario which you mention, which could prompt GLD and GDX to climb higher and likely…
Thanks for the replies! It seems that gold is more of a trade than a trend. Tempting, but I'll wait for the dust to settle and stay out of gold and the miners.
@little5bee I got lucky and read the tea leaves right. Sounds like your timing was good too! I can't give any advice about if the market's going to stay down, but my gut says it'll be extreme upswings and downswings for much of this year.
I agree with all that vkt said (typed?). Here's a case where I didn't follow the Bollinger bands:
I bought AAPL in late 2012 @ $620/share, after falling from a high of $702/share. Value trap city! I held onto those shares (because I believed in …
As I learned from 2008, cash ain't trash! Late last year I also learned that I should have diversified my investments more than I had, but I got lucky on that one.
I was heavily into health care until Hillary's August tweet attacking drug pricing …
I think that one needs to look at their reason for buying the investment, their time frame for holding the investment as well as how much risk they're willing to take on.
I've held funds and individual equities which took a beating and I dumped t…
Thanks for the suggestions! I'm not sure if I'll buy into any of these funds, but I wanted to know what else is out there besides XLY so that I can check them out.
Catch - That link is the motherload of Fido funds, thanks! I remember that we had …
I too would love to skewer the CEO of Turing...
Hillary's a politician who needed an excuse to change the media conversation about her away from her emails to another topic to improve her ratings. So she chose a sure-fire populist theme: healthca…
Interesting that no health care related logo is plastered onto Hillary's pantsuit in the facebook photo...
Being a cynic by nature, I'll agree with Scott's conclusion.
Hillary's focused on drug prices but this issue could spread to health care pricing in general, and on both sides of the aisle. The Republicans don't like Obamacare and Hillary wants to reign in drug prices. Either way, health care loses.
Like it or not drug pricing was bound to be an issue over the next year in the run-up to the election, at the likely expense of anything even remotely related to health care. Hillary waged war with the drug companies 20+ years ago and is doing so a…
I haven't backed up the truck with GILD shares, although I did purchase some more shares last Thursday. I'm overweight GILD in a diversified portfolio of funds/etf's and stocks and am providing facts to back up my thesis that GILD is currently an e…
Now GILD's price targets are predictably being raised:
S&P CAPITAL IQ REITERATES
STRONG BUY OPINION ON
SHARES OF GILEAD SCIENCES
Recent Price: $113.07
Recommendation:
FIVE STAR BUY [Highest Rating]
We raise our 12-month target $12 to $15…
My apologies for having momentarily hijacked this thread. I find this summary about GILD to be right on:
"What we're seeing come through is an under appreciation of all the hepatitis C revenues available outside the U.S.," said RBC Capital Markets…
The next 2 quarters will reveal GILD's expansion in countries outside of the USA, which is just beginning in Japan.
Mr. Market wants to see M&A activity from GILD. I prefer that GILD mgmt. do what is best for GILD. Can't argue with the number…
I'll be very interested in GILD's forward guidance as I think they'll top earnings estimates on Tuesday. GILD's Hep. C drugs are just getting started in large markets outside of the USA, like Japan for example. In my opinion, GILD can live off of …
I've been frustrated by GILD also. Yet sentiment toward GILD has changed since their most recent ER. One can look at GILD's chart since mid-April and say that the glass is half full, or the glass is half empty (which is my perspective).
While GIL…
@Scott - Nobody ever lost money by taking profits!
I agree with most everything that you've mentioned. Yet I think that the market has yet to fully price in the dominance of GILD's HCV cure as well as GILD's dominance in the global HCV market. I …
@Scott - You're the first person I've come across anywhere on the internet who thinks that GILD is overbought. I'm holding and not adding to my GILD position as it's a larger position than I want it to be, but I'm certainly not selling any GILD sha…
I added to my FSPHX holding this week. Still in GILD as I think it's undervalued, but I agree with the discussion that GILD is a frustrating stock. I've been through thick and thin with GILD. Both FSPHX and GILD are long term holdings for me.
I …
I'm an "emerging markets" traveler. I spent most of my early years in Thailand, so it's the country (outside of the USA) which I know best and is my fave country. Other countries I've visited, liked and would return to are (in no particular order)…
GILD has been the single most frustrating stock that I've been watching. Today might just be a short term bounce for GILD. Harvoni should be available in Japan in the 2nd half of this year as well as in various European countries where it's not ye…
Thanks for the years of links Ted. Glad you're set and thanks for keeping the links coming!
I might buy some GILD. GILD's blowout earnings and raised forecast could bode well for the entire biotech sector, which is in need of good news the kind …
I have neither the time nor the patience to watch (or listen to!) CNBC, but I come across CNBC video clips while researching funds/etf's/individual stocks. I have no idea who most of CNBC's guest "pros" are...
Only a handful of people working for my employer are over the age of 55. But I've learned that there is always an option!
Nobody on this board is aware of this fact, but I was born and spent my first 12 years of life living in Bangkok, Thailand as…
Being a cynic by nature, I also question the honesty of dentists. Dentists know that most people know little about teeth. I last saw a dentist in Nov. and he said that the next time I come in (May) I would need to get a crown. This advice came up…
